SIEMENS HEALTHINEERS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.18 EUR | -1.73% |
|
-5.08% | -2.70% |
| Mar. 27 | SIEMENS HEALTHINEERS : JP Morgan reiterates its Buy rating | ZD |
| Mar. 27 | SIEMENS HEALTHINEERS : Deutsche Bank reaffirms its Buy rating | ZD |
| Sales 2024 * | 22.75B 24.21B | Sales 2025 * | 24.34B 25.9B | Capitalization | 57.11B 60.78B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.06B 2.19B | Net income 2025 * | 2.58B 2.74B | EV / Sales 2024 * | 3.02 x |
| Net Debt 2024 * | 11.7B 12.46B | Net Debt 2025 * | 10.34B 11B | EV / Sales 2025 * | 2.77 x |
| P/E ratio 2024 * |
27.9
x | P/E ratio 2025 * |
22.3
x | Employees | 71,400 |
| Yield 2024 * |
2% | Yield 2025 * |
2.47% | Free-Float | 23.56% |
More Fundamentals
* Assessed data
More news
Latest transcript on Siemens Healthineers AG
More recommendations
More press releases
| 1 day | -1.73% | ||
| 1 week | -6.78% | ||
| Current month | -9.77% | ||
| 1 month | -8.38% | ||
| 3 months | -2.66% | ||
| 6 months | +6.89% | ||
| Current year | -2.70% |
1 week
50.98
54.66
1 month
50.9856.94
Current year
50.7658.14
1 year
44.3958.14
3 years
40.3267.66
5 years
28.5067.66
10 years
28.5067.66
| Managers | Title | Age | Since |
|---|---|---|---|
Bernhard Montag
CEO | Chief Executive Officer | 55 | 17-12-31 |
Jochen Schmitz
DFI | Director of Finance/CFO | 57 | 17-12-31 |
| Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dow Wilson
BRD | Director/Board Member | 64 | 22-10-31 |
Peer Schatz
BRD | Director/Board Member | 57 | 21-03-22 |
| Director/Board Member | 71 | 18-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.90% | 18 M€ | +7.68% | ||
| 1.48% | 2 M€ | +13.56% | - | |
| 1.11% | 962 M€ | -.--% | - | |
| 1.11% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 51.18 | -1.73% | 855,408 |
| 24-04-17 | 52.08 | -1.10% | 443,070 |
| 24-04-16 | 52.66 | -1.57% | 613,865 |
| 24-04-15 | 53.5 | +0.19% | 547,605 |
| 24-04-12 | 53.4 | -0.96% | 471,419 |
Delayed Quote Xetra, April 18, 2024 at 11:35 am EDT
More quotes
Siemens Healthineers AG is one of the world's No.1 manufacturers of equipment for medical imaging, laboratory diagnostics and hospital information systems. In addition, the group is developing digital health services and services dedicated to health establishments. Net sales break down by activity as follows:
- sale of imaging equipment and solutions (53%);
- sale of diagnostic equipment (21%);
- sale of solutions and services for cancer care (16.6%);
- sale of advanced therapeutic solutions (9.4%): for image-guided minimally invasive treatments in the areas of cardiology, interventional radiology and surgery.
Net sales are distributed geographically as follows: Germany (4.9%), Europe/CIS/Africa/Middle East (27.3%), the United States (34.6%), America (6.3%), China (13%) and Asia/Pacific and Japan (13.9%).
Calendar
2024-05-06
- Q2 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
51.18
EUR
Average target price
60.33
EUR
Spread / Average Target
+17.88%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.70% | 61.83B | |
| +2.02% | 209B | |
| +2.17% | 177B | |
| +10.45% | 133B | |
| +16.62% | 99.89B | |
| +13.38% | 52.51B | |
| -6.33% | 45.54B | |
| -4.74% | 39.43B | |
| +9.89% | 38.87B | |
| +3.25% | 25.53B |
- Stock Market
- Equities
- SHL Stock
